CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.3B
1-Year Est. Return 45.88%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$92.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
543
New
Increased
Reduced
Closed

Top Buys

1
+$16.2M
2
+$6.26M
3
+$4.07M
4
META icon
Meta Platforms (Facebook)
META
+$3.94M
5
RACE icon
Ferrari
RACE
+$2.98M

Top Sells

1
+$11.5M
2
+$7.75M
3
+$6.78M
4
ORCL icon
Oracle
ORCL
+$2.75M
5
RCL icon
Royal Caribbean
RCL
+$2.72M

Sector Composition

1 Technology 37.86%
2 Healthcare 22.63%
3 Communication Services 13.04%
4 Consumer Discretionary 10.29%
5 Consumer Staples 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTA icon
426
Enanta Pharmaceuticals
ENTA
$405M
$74.2K 0.01%
4,703
-4,044
XBI icon
427
State Street SPDR S&P Biotech ETF
XBI
$8.09B
$74.1K 0.01%
608
-4,311
ETON icon
428
Eton Pharmaceutcials
ETON
$467M
$73.9K 0.01%
+4,370
PEPG icon
429
PepGen
PEPG
$423M
$72.9K 0.01%
11,202
+5,453
SLDB icon
430
Solid Biosciences
SLDB
$637M
$71.6K 0.01%
12,695
-954
SIGA icon
431
SIGA Technologies
SIGA
$405M
$71.3K 0.01%
11,669
-882
CYD icon
432
China Yuchai International
CYD
$1.63B
$71K 0.01%
2,000
EOLS icon
433
Evolus
EOLS
$342M
$70.2K 0.01%
10,562
-776
FDMT icon
434
4D Molecular Therapeutics
FDMT
$452M
$69.8K 0.01%
9,310
+1,124
NBP
435
NovaBridge Biosciences American Depositary Shares
NBP
$374M
$67.4K 0.01%
+16,940
KYTX icon
436
Kyverna Therapeutics
KYTX
$550M
$67.1K 0.01%
7,137
-443
KMDA icon
437
Kamada
KMDA
$517M
$66.4K 0.01%
+9,399
AUTL
438
Autolus Therapeutics
AUTL
$426M
$65K 0.01%
32,687
-2,470
TRDA icon
439
Entrada Therapeutics
TRDA
$505M
$64K ﹤0.01%
6,228
-439
RCKT icon
440
Rocket Pharmaceuticals
RCKT
$575M
$61.9K ﹤0.01%
17,635
-1,279
ALT icon
441
Altimmune
ALT
$483M
$61.4K ﹤0.01%
17,003
+1,533
CAMP icon
442
CAMP4 Therapeutics
CAMP
$314M
$61.3K ﹤0.01%
+10,000
AURA icon
443
Aura Biosciences
AURA
$358M
$56.4K ﹤0.01%
10,348
-541
BCYC
444
Bicycle Therapeutics
BCYC
$368M
$53.4K ﹤0.01%
7,540
-564
ACRS icon
445
Aclaris Therapeutics
ACRS
$444M
$53.1K ﹤0.01%
+17,655
LRMR icon
446
Larimar Therapeutics
LRMR
$581M
$53.1K ﹤0.01%
13,947
-1,056
NGNE icon
447
Neurogene
NGNE
$357M
$52K ﹤0.01%
2,524
+22
AVXL icon
448
Anavex Life Sciences
AVXL
$430M
$51.8K ﹤0.01%
14,559
-497
ACIU icon
449
AC Immune
ACIU
$306M
$51.4K ﹤0.01%
16,362
-1,238
CADL icon
450
Candel Therapeutics
CADL
$374M
$50.5K ﹤0.01%
+8,946
16 17
18
19 20